Orbsen Therapeutics happy with interim diabetic kidney disease study results
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
This week, we have two guests. We have conversations with Newron CEO, Stefan Weber, and…
Newron Pharmaceuticals S.p.A. has announced what it says are “very compelling new results” from the…
The IRBM Group is an innovative research and discovery CRO (contract research organization) working across…
Discovering new drugs remains an inefficient, trial and error-based process. The founding team behind the…
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been…
An impressive crowd gathered at Chiesi Pharmaceutical Group yesterday (November 21) to mark the much-anticipated…
Metastatic prostate cancer is a leading cause of cancer death in men worldwide. Interleukin (IL)-30,…
Reveal Genomics, S.L. says it has received more validation of HER2DX, the world's first specialized…
The first patient has been dosed in a phase 2 pilot study looking at a…
AGC Biologics has announced its partnership with supplier of human mesenchymal stem/stromal cells (hMSCs), RoosterBio…
A new development partnership between gene therapy company Altheia Sciences, which pioneers cell and gene…